Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ADCYAP1 Primary Antibody for ELISA, WB - ABIN4343354
Bourgault, Vaudry, Botia, Couvineau, Laburthe, Vaudry, Fournier: Novel stable PACAP analogs with potent activity towards the PAC1 receptor. in Peptides 2008
PACAP stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells
High level of co-expression of PACAP with VIP, SP and CGRP in the distal ganglia of the vagus sensory perikarya directly implicates studied peptides in their functional interaction during nociceptive vagal transduction.
The release of biologically active PACAP was described in mast cells; providing a potential biological explanation for the association between allergy and migraine.
that perturbations in the PACAP-PAC1R pathway may be involved in amyotrophic lateral sclerosis pathology
Results have suggested that pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP), but predominantly VIP, induce neuroblastoma differentiation into benign form by regulating hypoxia-inducible factors, vascular endothelial growth factor and vascular endothelial growth factor receptor expression and distribution.
human migraine models have shed light on the importance of PACAP38 in the pathophysiology of primary headaches
PACAP stimulated repairing of corneal endothelium lesion as shown by wound healing analysis.
Studies suggest that the level of stress and circulating gonadal hormones may differentially regulate the PACAPergic system in males and females to influence anxiety-like behavior and may be one mechanism underlying the discrepancies in human psychiatric disorders. [Review Article]
Study indicates that both exogenous and endogenous pituitary adenylate cyclase activating polypeptide plays a regulatory role in small intestinal cells, but this is restricted to certain conditions, such as type of stressor and timing of application.
Some abnormalities of the PACAP system are evident in the brains of Sudden Infant Death Syndrome infants.
Study found that interictal serum PACAP levels are not increased (or decreased) in a large series of chronic migraine women when compared to matched controls without a headache history
Study found a protective effect of PACAP-38 on oxidative stress damage in zebrafish hair cells, suggesting PACAP-38 ability to prevent hair cells from apoptosis. PACAP-38 treatment decreased the cleaved caspase-3 level in the hair cells, but somewhat unexpectedly had no influence on p-38 MAPK pathway. PACAP-38 treatment also rescued H2O2-induced reduction in movement.
An association was found in a common variant of the PACAP receptor in patients with cluster headache.
It has potent neuroprotective and neuroregenerative functions. (review)
PACAP-38 is released in plasma during attacks of episodic cluster headache patients.
Hypermethylation of ADCYAP1 gene may be highly associated with the development of cervical cancer.
This review provides an overview of current knowledge regarding the neuroprotective effects, mechanisms of action, and therapeutic potential of PACAP in response to ischemic brain injuries
PACAP is involved in the pathogenesis of migraine rather than tension-type headache
PACAP38-PAC1 signaling process initiates bone marrow-derived cells homing into the ischemic brain for reducing brain injury.
Results suggest that PACAP could protect SH-SY5Y dopaminergic cells against toxicity induced by inflammatory mediators.
PACAP released from retinal neural cells (photoreceptors or optic nerve cells) may regulate Sema4A expression in retinal pigment epithelial cells and thereby contribute to the maintenance of retinal structure and function.
The Asp54Gly (rs2856966) variant in the PACAP gene was associated with better treatment outcome.
the results demonstrated that autophagy is induced in Parkinson's disease experimental models and that PACAP exhibits not only anti-apoptotic but also anti-autophagic properties.
Results show that lack of pituitary adenylate cyclase-activating polypeptide (PACAP) influences molecular and biomechanical properties of bone matrix, activating various signalling cascade changes in a compensatory fashion.
Low PACAP expression is associated with increased number of severely damaged sperms.
results suggest that IL-6 gene requires up-regulation of phospho-JAK2/STAT3, PACAP, and PAC1R and down-regulation of the TNF-alpha gene to modulate its anticonvulsive/neuroprotective potential
The data presented here shows PACAP38 transport is temporally altered following controlled cortical impact -treatment and PACAP38 uptake is greater in the cerebellum compared to the cortices
In conclusion, Pituitary adenylate cyclase activating polypeptidecan attenuate Mitoxantrone -mediated left ventricular dilation and dysfunction in mice.
This study shown the model of depression in PACAP mutation mice.
PACAP/PAC1 signaling is important for light regulated behavior, VIP/VPAC2 signaling for stable clock function and both signaling pathways may play a role in shaping diurnality versus nocturnality.
Results suggests that PACAP regulates a bidirectional interaction between the adult neural progenitor cells and their niche: PACAP modifies extracellular matrix production and remodeling, in turn the extracellular matrix regulates progenitor cell adherence. PACAP may in this manner help restrict adult neural progenitors to the stem cell niche in vivo.
age-related changes were observed in the PACAP KO mice only. These alterations included horizontal and rod bipolar cell dendritic sprouting into the photoreceptor layer and decreased ganglion cell number. Also, Muller glial cells showed elevated GFAP expression compared to the aging WT retinas.
Mice lacking endogenous PACAP have slower weight gain during the first weeks of development and slower neurobehavioral development.
Study investigated effects of chronic variable mild stress (CVMS) in non-injected, vehicle and imipramine-treated KO mice vs. wildtype (WT) counterparts and mapped the CVMS-related FosB response in 18 brain areas; found that PACAP deficiency affects neuronal reactivity in a brain area-specific manner in stress centers
Backup mechanisms maintain PACAP/VIP-induced arterial vasodilation in PACAP-deficient mice.
PACAP/PAC1 signaling has a role in light regulated food anticipatory activity
PACAP deficient mice exhibit attenuated acute restraint stress response and chronic restraint stress response.
not only homozygous but also heterozygous PACAP deficient mice are more vulnerable to kidney ischemia/reperfusion, further supporting the nephroprotective effects of the endogenous PACAP
PACAP expression in the dorsal root ganglion following spinal nerve injury is controlled through transcriptional repressor, REST.
This study demonstrated that Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide.
PACAP shows morphological actions via its cognate receptor PAC1.
This study suggests that PACAP(-/-) mice are an ideal rodent model with predictive validity for the study of ADHD etiology and drug development.
The temporal and spatial expression pattern of the ghrh-pacap1 transcript suggests that thise hormones may modulate patterning during development.
signal pathways, transcript distribution, and splice variants are investigated
expression of transcripts for PACAP and its receptors by 0.5-6 hpf make both PACAP1 and PACAP2 candidates for factors that influence brain development
study reveals the distribution of immunoreactive GHRH-like peptide in structures of the zebrafish brain; results suggest involvement of GHRH-LP in both neuroendocrine and feeding-associated nervous circuits
This gene encodes a secreted proprotein that is further processed into multiple mature peptides. These peptides stimulate adenylate cyclase and increase cyclic adenosine monophosphate (cAMP) levels, resulting in the transcriptional activation of target genes. The products of this gene are key mediators of neuroendocrine stress responses. Alternative splicing results in multiple transcript variants.
glucagon family neuropeptides
, growth hormone-releasing hormone
, pituitary adenylate cyclase-activating polypeptide
, pituitary adenylate cyclase activating polypeptide
, adenylate cyclase activating peptide, pituitary 1
, adenylate cyclase activating polypeptide 1 (pituitary)
, pituitary adenylate cyclase activating polypeptide 1
, pituitary adenylate cyclase-activating polypeptide precursor (Pacap)
, pituitary adenylate cyclase activating polypeptide, PACAP